@2000ManBioTech@Pyrazoleurea@adamfeuerstein Why must we all agree that we’ve reached the end of days for biomedical innovation? That’s indeed what we disagree on. It’s what people thought 20 years ago and many times since. Every time market drops, someone assumes it’s the end. Always wrong to bet against progress.
369 Followers 7K FollowingAksjeinvestor med hovedfokus pà selskaper som betaler kvartalsvis- og ärlig utbytte. Folg min reise mot okonomisk frihet pa https://t.co/6W7BmUnC38
224 Followers 329 Followingbiotech news and sideline chirps - not investment advice. Running the biochirp (s)ub(s)tack linked below. Building early stage biotech from 9-5.
33K Followers 34K FollowingPresident and Chief Scientific Officer of Immorta Bio Inc
460 published and issued patents
Multiple Exits
#biotech #longevity #immunology #FoxpP3 #SenoVax
540 Followers 2K FollowingNews Portal for BioTech, MedTech, and HealthTech News - Don't Waste your time trying to find Live, Curated, and Searchable News on BioTech + More!
2K Followers 3K FollowingWe provide the world’s leading pharma and biotech companies with solutions for #PrecisionMedicine commercial strategies. #BetterTestingBetterTreatment
4K Followers 413 FollowingArbs • +EV • Projection Models | More than $150K profit since Oct 2024 | Co-Founder @EdgeZoneHQ | This isn’t just a community... it’s a movement. Be part of it!
3K Followers 80 FollowingCharts and an Occasional Opinion. Not Financial advice. I like a good debate and look forward to being proven Wrong by a better argument. Have at it :-)
52K Followers 623 FollowingNot selling anything.
Not investment advice.
Personal but public journal.
Arguing with you to spare my family.
DM a mutual friend to unblock.
58K Followers 276 FollowingProfessional equity and option trade ideas with in-depth research based on 3-pronged approach: Fundamentals, Technicals and Options Activity
993 Followers 899 FollowingI am a Neonatologist, MBA, Yale and MIT trained. Investor Trader doing ad hoc analysis of firms in the Life Sciences. Tweets are not implied Investment Advice